The pathogenetic role of NFκB has been demonstrated in many diseases from cancer to cardiovascular diseases [80,81,82], where it exerts a double effect: regulation of immunity by driving the expression of genes involved in inflammation [83] and regulation of the expression of specific target genes involved in the progression of the pathology. The gene discussed is NFKB1; the disease is cancer.